Navigation Links
Investor Insight Initiates Analyst Coverage on Crdentia
Date:2/11/2008

Analyst Rates Speculative Buy, $0.61 Price Target

DALLAS, Feb. 11 /PRNewswire-FirstCall/ -- Crdentia Corp. (OTC Bulletin Board: CRDT), a leading healthcare staffing company, today announced that the independent research firm Investor Insight, an operating division of Doty-Scott Enterprises, initiated coverage on the Company. The report is available at http://www.crdentia.com/corporate/about/investor/ and through http://www.dotyscott.com and http://www.audiostocks.com.

About Crdentia Corp.

Crdentia Corp., one of the nation's leading providers of healthcare staffing solutions, is focused on recruiting talented national and international healthcare professionals to meet the ever-increasing employment needs of over 2,300 clients. Crdentia is one of the few companies that can provide quality temporary staff for all healthcare industry positions including local nurses, travel nurses, allied health, locum tenens and home care professionals. For more information, visit http://www.crdentia.com.

Forward Looking Statements

Statements contained in this release that are not historical facts are forward-looking statements that involve risks and uncertainties. Among the important factors which could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, those discussed in "Risk Factors" in the Company's Forms 10-K, Forms 10-Q, and other filings with the Securities and Exchange Commission. Such risk factors include, but are not limited to, a limited operating history with no earnings; reliance on the Company's management team, members of which have other business interests; the ability to successfully implement the Company's business plan; the ability to continue as a going concern; the ability to fund the Company's business and acquisition strategy; the growth of the temporary healthcare professional staffing business; difficulty in managing operations of acquired businesses; uncertainty in government regulation of the healthcare industry; and the limited public market for the Company's common stock. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. Crdentia undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Contact Crdentia Corp.

John Kaiser, CEO

Phone: 972.850.0780

Fax: 972.392.2722

jkaiser@crdentia.com

Jim TerBeest, CFO

Phone: 972.850.0780

Fax: 972.392.2722

jterbeest@crdentia.com


'/>"/>
SOURCE Crdentia Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
2. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
3. MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc.
4. Assurant President and Chief Executive Officer Robert B. Pollock to Present at Merrill Lynch Insurance Investor Conference on February 12
5. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
6. Torchmark Corporation to Present at Merrill Lynch Insurance Investors Conference
7. MaxCyte to Present at the BIO CEO & Investor Conference
8. Sharps Compliance Corp. to Present at the RedChip Small-Cap Investor Conference in Scottsdale, Arizona
9. Vical to Present at BIO CEO and Investor Conference
10. ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
11. NPS Pharmaceuticals to Present at BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... ... senior director at PolicyLink, will be the keynote speaker at its second Professional ... Men of Color Framework, which develops comprehensive strategies to create and expand opportunities ...
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who ... directly related to surgery, treatment, therapy and management. Regular exercise in proper environments ... of life despite their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a ...
(Date:2/21/2017)... ... February 21, 2017 , ... American Veterinarian™, the premier ... be launching its first bi-monthly issue of 2017 in February. The inaugural issue ... and One Health. , In making the announcement, American Veterinarian™ Publisher Chris ...
(Date:2/21/2017)... ... February 21, 2017 , ... Atlanta-based ... predictive analytic firm Predixion’s Healthcare IT practice. Predixion, which raised $42M+ to date, ... by giants including Accenture, GE Ventures, and Software AG , will bring ...
(Date:2/21/2017)... ... ... A February 6 article on Healio describes a recent review ... treatments have led to significant improvements in weight loss and other health outcomes resulting ... very few problematic results relating to the treatment. Beverly Hills Physicians (BHP) says that ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... , Feb. 21, 2017 Diabetic Shoes Market: ... ... can be described as a disease, which is marked by ... production and insulin action. The disease has become a global ... death. Diabetes affects several organs of the body including eyes, ...
(Date:2/21/2017)... Feb. 21, 2017  Global health services company Cigna ... ® for breast reconstruction surgery and Dermacell ... an advanced acellular dermal matrix developed by LifeNet Health ... NVDQ ) "We are proud ... health-care payers to review the growing base of evidentiary ...
(Date:2/21/2017)... Ky. , Feb. 21, 2017 ... imaging leader, today announced a new imaging solution that connects ... Solarity® platform, one of the world,s leading scanning and ... The Solarity Connector enables hospitals to use a Lexmark ... information into the Solarity workflow, helping facilities reach ...
Breaking Medicine Technology: